In the bone marrow of every person there is an orchestra of cells that plays the symphony of blood each day: red blood cells carry oxygen, white blood cells defend against infections, platelets patch up damage. The conductors are hematopoietic stem cells, rare cells capable of producing any blood cell. While the orchestra is young, every part sounds in harmony. But with age, some of the musicians start playing off-key: these are aged cells that have stopped dividing yet never left the stage. They release inflammatory substances, like a violinist who coughs loudly during the rests and throws everyone else off the beat. Because of them, stem cells increasingly play the same part over and over: myeloid cells, which drive inflammation, while the lymphocytes responsible for immunity are left without their notes. Immunity weakens, inflammation grows, and the risk of leukemias rises.
Scientists decided to remove the off-key musicians. First they used genetically modified mice in which cells with an active p16 gene, a marker of aging, can be selectively killed with the drug ganciclovir. The mice were treated from 12 to 24 months of age, and then their bone marrow was tested. The result was striking: after the cleanup, the frequency of functional stem cells rose from 1 in 83 to 1 in 11, almost catching up with young donors (1 in 9). The balance of blood lineages was restored: the myeloid skew shrank, and lymphocytes became more numerous. The supporting cells of the bone marrow, the stroma, came back to life too: they released fewer inflammatory molecules and did a better job of helping stem cells grow in culture.
But a genetic model is a laboratory trick that cannot be carried over into the clinic. So the researchers tested a new drug, 753b, which destroys the BCL-2 and BCL-XL proteins. These proteins shield aged cells from death, and 753b strips them of that protection. Old mice around 22 months of age received eight injections of the drug at three-day intervals. The effect turned out to be similar to the genetic cleanup: markers of aging fell, the balance of progenitor cells was restored, and the transcriptomes of stem cells, the sets of active genes, shifted toward a youthful state. Most importantly, the drug did not cause thrombocytopenia, that is, it did not drop platelet levels to a dangerous point. In the old mice, platelet counts after treatment fell to the level seen in young animals, but no lower. This removes the main obstacle to long-term therapy.
An analysis of cell-to-cell communication showed that aging weakens the supportive signals from the stem cell niche but strengthens inflammatory ones. Treatment partially restores the youthful architecture of signals. This means that removing aged cells strikes on two fronts at once: the stem cells themselves and their microenvironment, which amplifies the effect. Previously it was unclear whether aged bone marrow cells could be safely removed and age-related decline in blood formation reversed without harming platelets. Now it is clear: they can, and the drug 753b is the first candidate that does this without toxicity. In the future, such therapy could help with age-related anemia, immunodeficiency, and possibly the prevention of myeloid leukemias.
The orchestra is playing at full strength again. The off-key musicians, now removed, no longer drown out the young ones, and the stem cells remember their parts. Of course, this is still mice, not people, and the clinic is a long way off. But for the first time we have a tool that does not merely slow the aging of the blood-forming system but partially reverses it, without breaking the orchestra itself. And if doctors ever manage to clean the bone marrow of aged cells as routinely as a dentist removes tartar, old age will no longer be a death sentence for immunity.
In old mice treated with 753b, platelet counts fell to the level of young animals but no lower, meaning the drug corrected the age-related increase rather than causing thrombocytopenia.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.